A5004121956- Photodynamic Therapy Research Studies
- Nanoplatforms for cancer theranostics
- Porphyrin and Phthalocyanine Chemistry
- Cancer, Hypoxia, and Metabolism
- Ocular Oncology and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
- Spectroscopy and Chemometric Analyses
- Renal Transplantation Outcomes and Treatments
- HIV-related health complications and treatments
- Computational Drug Discovery Methods
- Hepatitis C virus research
- Analytical Chemistry and Chromatography
Bicêtre Hospital
2013-2017
Assistance Publique – Hôpitaux de Paris
2013-2017
Centre National de la Recherche Scientifique
2011-2012
Université Paris-Sud
2009-2012
Institut Curie
2011-2012
Université Toulouse III - Paul Sabatier
2012
Laboratoire COBRA
2012
Institut Galien Paris-Saclay
2011
Laboratoire de Chimie
2009
In this paper, we discuss the evolution over last 15 years in Curie Institute of concept, development design and some properties glycoconjugated photosensitizers with aim to optimize tumor targeting photodynamic therapy. By research, have shown that specific interactions between a mannose-lectin trimannosylglycodendrimeric porphyrins contributed larger extent than non-specific ones overall interaction glycosylated tetraarylporphyrin membrane. The studies vitro photocytotoxicity showed...
What is known and objective Azole antifungals, prescribed prophylactically to avoid severe infections in immunosuppressed organ transplant recipients, can interact with drug substrates of CYP3A4. We report serious adverse effects due interaction between orally administered voriconazole everolimus a renal recipient. Case description Despite reduction the dose by third, blood trough concentration increased considerably kidney recipient upon oral administration voriconazole. Everolimus was then...
Abstract Review: 79 refs.